Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Isoliquiritigenin in breast cancer therapy: from mechanistic insights to advanced nano-enabled delivery strategies.

Isoliquiritigenin (ISL), a chalcone from Glycyrrhiza species, exhibits multi-target anti-breast cancer activity but faces pharmacokinetic limitations. This review synthesizes evidence for ISL's molecular targets and mechanisms and evaluates nano-delivery strategies. In preclinical models, ISL inhibits proliferation via...

Kumar Ganesan, Yuan-Ze Gao, Fei Gao et al. · 0 citations
Review Sep 2026

AI virtual cells for drug discovery and pharmacology.

The resources and modeling advances supporting AI virtual cells' value for mechanism-of-action analysis, efficacy, safety, resistance, and combination studies are reviewed, and evidence requirements for pharmacological use are defined.

Shi-Hang Wang, Yang Zhang, Dong Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.